AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32819999 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnosis (only microbiological routine testing)
Number of subjects: 440
Study 35654025 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical gemcitabine + docetaxel (Gem/Doce)
Number of subjects: 60
Study 35654025 — intervention group
Group type: COMPARATOR
Intervention: BCG
Number of subjects: 60
Study 33601334 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily feedback
Number of subjects: 57
Study 33601334 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent incentives
Number of subjects: 57
Study 33601334 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of daily feedback and contingent incentives
Number of subjects: 57
Study 33601334 — intervention group
Group type: COMPARATOR
Intervention: Weekly feedback
Number of subjects: 57
Study 33601334 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent incentives
Number of subjects: 57
Study 32536056 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue recipe
Number of subjects: 207
Study 32536056 — intervention group
Group type: COMPARATOR
Intervention: Fuzheng Huayu capsule
Number of subjects: 207
Study 35138767 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with medical care
Number of subjects: 203
Study 35138767 — intervention group
Group type: COMPARATOR
Intervention: Medical care alone
Number of subjects: 203
Study 33932360 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for 12 months
Number of subjects: 134
Study 35835446 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal breathing
Number of subjects: 198
Study 33863614 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised formal physical therapy (PT)
Number of subjects: 147
Study 33863614 — intervention group
Group type: COMPARATOR
Intervention: Self‐directed home exercises
Number of subjects: 147
Study 36372120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal ventilation exercise (NV+PR)
Number of subjects: 19
Study 36372120 — intervention group
Group type: COMPARATOR
Intervention: Voluntary hypoventilation (vHV+PR)
Number of subjects: 19
Study 34261995 — intervention group
Group type: EXPERIMENTAL
Intervention: Judo (120-min per week for 3 months)
Number of subjects: 44
Study 34261995 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 44
Study 35689191 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Youngsters, Healthy Dads (HYHD) program
Number of subjects: 125
Study 35689191 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 125
Study 34222141 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative Music Therapy (CMT)
Number of subjects: 82
Study 34222141 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 82
Study 32534250 — intervention group
Group type: EXPERIMENTAL
Intervention: External trigeminal nerve stimulation (ETNS)
Number of subjects: 40
Study 32534250 — intervention group
Group type: COMPARATOR
Intervention: Usual medical treatment (Control)
Number of subjects: 40
Study 35672789 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision group
Number of subjects: 20
Study 35672789 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 35672789 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 32748071 — intervention group
Group type: EXPERIMENTAL
Intervention: FOI with tongue root holder
Number of subjects: 300
Study 33982238 — intervention group
Group type: EXPERIMENTAL
Intervention: AC group (anesthesia consultation group)
Number of subjects: 186
Study 33982238 — intervention group
Group type: COMPARATOR
Intervention: POP group (standard postoperative group)
Number of subjects: 186
Study 34197641 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Foley catheter (DFC)
Number of subjects: 222
Study 34197641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cook cervical ripening balloon
Number of subjects: 222
Study 34197641 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter (FC)
Number of subjects: 222
Study 32243994 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised treatment (exercise, education, diet, insoles, and pain medication)
Number of subjects: 100
Study 32243994 — intervention group
Group type: COMPARATOR
Intervention: Written advice
Number of subjects: 100
Study 36319990 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally tailored preconception care (PCC) intervention with a social marketing strategy
Number of subjects: 850
Study 36319990 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally tailored preconception care (PCC) intervention
Number of subjects: 850
Study 35053648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy combined with Schroth exercises
Number of subjects: 52
Study 35053648 — intervention group
Group type: COMPARATOR
Intervention: Schroth exercises alone
Number of subjects: 52
Study 33977825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 0
Study 33977825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32131886 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized acupuncture
Number of subjects: 1100
Study 32131886 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed acupuncture
Number of subjects: 1100
Study 32131886 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 1100
Study 32131886 — intervention group
Group type: COMPARATOR
Intervention: Placebo letrozole
Number of subjects: 1100
Study 34087337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac glycosides (CGs)
Number of subjects: 5311
Study 34087337 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation at enrollment
Number of subjects: 5311
Study 36201753 — intervention group
Group type: EXPERIMENTAL
Intervention: EstroSense®
Number of subjects: 148
Study 33586476 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary, group-based programme using a cognitive-behavioural approach, 6 sessions of 2 hours duration
Number of subjects: 130
Study 32468719 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg fingolimod HCl capsule (Lebrina)
Number of subjects: 33
Study 32468719 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg fingolimod capsule (Gilenya)
Number of subjects: 33
Study 32468719 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of fingolimod
Number of subjects: 33
Study 35685899 — intervention group
Group type: EXPERIMENTAL
Intervention: basic treatment + electroacupuncture
Number of subjects: 150
Study 35685899 — intervention group
Group type: COMPARATOR
Intervention: basic treatment
Number of subjects: 150
Study 34309987 — intervention group
Group type: EXPERIMENTAL
Intervention: Melissa officinalis tea (MO tea), 2-g dried leaves/250 mL in hot water, two times/day for 12 weeks, in addition to lifestyle modification recommendations.
Number of subjects: 60
Study 34309987 — intervention group
Group type: COMPARATOR
Intervention: Control group received lifestyle modification recommendations only.
Number of subjects: 60
Study 36227682 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural block with dezocine and ropivacaine
Number of subjects: 60
Study 36227682 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 60
Study 33185582 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 33059801 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose intramuscular injection of vitamin D3 (10,000 IU/kg)
Number of subjects: 59
Study 33059801 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin D3 drops (900 IU/d) for 25 days
Number of subjects: 59
Study 35583869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Coaching (LC)
Number of subjects: 1761
Study 35583869 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Pharmacotherapy (EP)
Number of subjects: 1761
Study 35583869 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1761
Study 32697726 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzzy static output‐feedback controller (SOFC)
Number of subjects: 0
Study 32697726 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzzy filtering
Number of subjects: 0
Study 32665410 — intervention group
Group type: EXPERIMENTAL
Intervention: Celebrity webinar
Number of subjects: 721
Study 32665410 — intervention group
Group type: EXPERIMENTAL
Intervention: Celebrity video
Number of subjects: 721
Study 32665410 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor webinar
Number of subjects: 721
Study 32665410 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 721
Study 35394515 — intervention group
Group type: EXPERIMENTAL
Intervention: Gram stain-guided antibiotic therapy
Number of subjects: 206
Study 35394515 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based antibiotic therapy
Number of subjects: 206
Study 33714824 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz diorite
Number of subjects: 24
Study 33714824 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomb porphyry
Number of subjects: 24
Study 33714824 — intervention group
Group type: COMPARATOR
Intervention: Lactose (placebo dust)
Number of subjects: 24
Study 33714824 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz diorite, Rhomb porphyry, Lactose
Number of subjects: 24
Study 32421638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile cues
Number of subjects: 0
Study 32421638 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues
Number of subjects: 0
Study 32421638 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech cues
Number of subjects: 0
Study 32421638 — intervention group
Group type: COMPARATOR
Intervention: No cueing (Control)
Number of subjects: 0
Study 32421638 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal cue pairings
Number of subjects: 0
Study 35428577 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste and NovaMin (Sensodyne® Repair and Protect, England)
Number of subjects: 38
Study 35428577 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste (Sensodyne® Rapid Relief, England)
Number of subjects: 38
Study 32189338 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 14 mg/kg/d
Number of subjects: 175
Study 32189338 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 7 mg/kg/d
Number of subjects: 175
Study 32189338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 35725421 — intervention group
Group type: EXPERIMENTAL
Intervention: Amandla Mama mHealth videos, short 2D animated health promotional videos that promote healthy behavior in expectant mothers.
Number of subjects: 450
Study 32189646 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly persons in old age homes
Number of subjects: 334
Study 32189646 — intervention group
Group type: EXPERIMENTAL
Intervention: Men in old age homes
Number of subjects: 334
Study 32189646 — intervention group
Group type: EXPERIMENTAL
Intervention: Women in old age homes
Number of subjects: 334
Study 32189646 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly persons aged ≥80 years
Number of subjects: 334
Study 34649262 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐lactalbumin (A‐LAC)
Number of subjects: 16
Study 34649262 — intervention group
Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 16
Study 34649262 — intervention group
Group type: COMPARATOR
Intervention: Placebo (whey protein)
Number of subjects: 16
Study 36233538 — intervention group
Group type: EXPERIMENTAL
Intervention: Hochuekkito (TJ‐41) treatment combined with pulmonary rehabilitation (PR) for 12 weeks
Number of subjects: 0
Study 36233538 — intervention group
Group type: COMPARATOR
Intervention: Control group (low-intensity exercise without TJ‐41 treatment) for 12 weeks
Number of subjects: 0
Study 35174607 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fat‐loss lotion containing Coleus forskholii, Silybin, Eucommia ulmoides leaf, Paullinia cupana seed, caffeine, and black pepper essential oil applied twice daily for 8 weeks
Number of subjects: 20
Study 35174607 — intervention group
Group type: COMPARATOR
Intervention: Placebo control lotion applied to the same sites on the other leg
Number of subjects: 20
Study 35174607 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fat‐loss lotion
Number of subjects: 20
Study 32654917 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy (not specified in detail)
Number of subjects: 30
Study 32654917 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy patients)
Number of subjects: 30
Study 35085837 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP-RFA
Number of subjects: 57
Study 35085837 — intervention group
Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 57
Study 32570126 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood patch pleurodesis (100 mL autologous blood injected at days 5 and 6)
Number of subjects: 24
Study 32570126 — intervention group
Group type: COMPARATOR
Intervention: Observation (no intervention)
Number of subjects: 24
Study 32570126 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical revision (Group C)
Number of subjects: 24
Study 34718341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 72
Study 34718341 — intervention group
Group type: COMPARATOR
Intervention: Supportive Therapy (ST) for 12 weeks
Number of subjects: 72
Study 33450188 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass-pollen sublingual immunotherapy
Number of subjects: 0
Study 33450188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35529454 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral continuous theta-burst stimulation (Bi-cTBS)
Number of subjects: 15
Study 35529454 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral intermittent theta-burst stimulation (Uni-iTBS)
Number of subjects: 15
Study 35529454 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral intermittent theta-burst stimulation (Bi-iTBS)
Number of subjects: 15
Study 35529454 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 34259636 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive animation (n=72)
Number of subjects: 206
Study 34259636 — intervention group
Group type: EXPERIMENTAL
Intervention: Text condition (n=65)
Number of subjects: 206
Study 34259636 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n=69)
Number of subjects: 206
Study 34259636 — intervention group
Group type: COMPARATOR
Intervention: Immersive animation vs Control
Number of subjects: 206
Study 34259636 — intervention group
Group type: COMPARATOR
Intervention: Text vs Control
Number of subjects: 206
Study 34259636 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive animation vs Text
Number of subjects: 206
Study 33269837 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints Neiguan (PC6) + Hegu (LI4) for 30 min before anesthesia until the end of the operation
Number of subjects: 140
Study 33269837 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints PC6 + LI4 + Zusanli (ST36) for 30 min before anesthesia until the end of the operation
Number of subjects: 140
Study 33269837 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints PC6 + LI4 + ST36 + Sanyinjiao (SP6) for 30 min before anesthesia until the end of the operation
Number of subjects: 140
Study 33269837 — intervention group
Group type: COMPARATOR
Intervention: GA control group receiving intravenous Midazolam, Sufentanil, Propofol, Rocuronium Bromide
Number of subjects: 140
Study 36149465 — intervention group
Group type: EXPERIMENTAL
Intervention: Early iron supplementation
Number of subjects: 0
Study 36149465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34941936 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective of passengers
Number of subjects: 0
Study 34941936 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective of pedestrians
Number of subjects: 0
Study 34941936 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective of observers
Number of subjects: 0
Study 34941936 — intervention group
Group type: EXPERIMENTAL
Intervention: Fifth experiment testing social desirability bias
Number of subjects: 0
Study 34941936 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall moral preferences
Number of subjects: 0
Study 35378077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabotegravir with TDF-FTC placebo
Number of subjects: 3224
Study 35378077 — intervention group
Group type: COMPARATOR
Intervention: TDF-FTC with cabotegravir placebo
Number of subjects: 3224
Study 35378077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabotegravir
Number of subjects: 3224
Study 35378077 — intervention group
Group type: COMPARATOR
Intervention: TDF-FTC
Number of subjects: 3224
Study 32393096 — intervention group
Group type: EXPERIMENTAL
Intervention: oXiris haemofilter
Number of subjects: 35
Study 32231356 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern contraceptive use among 15-19 year-olds (51.7% using LARC)
Number of subjects: 1022
Study 32231356 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern contraceptive use among 20-24 year-olds (36.5% using LARC)
Number of subjects: 1022
Study 32231356 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet need for contraception among 15-19 year-olds
Number of subjects: 1022
Study 32231356 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet need for contraception among 20-24 year-olds
Number of subjects: 1022
Study 32231356 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with modern contraceptive use
Number of subjects: 1022
Study 35745267 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement
Number of subjects: 463
Study 35745267 — intervention group
Group type: COMPARATOR
Intervention: Control group (lifestyle intervention alone)
Number of subjects: 463
Study 33706829 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agroecology intervention
Number of subjects: 548
Study 33706829 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 548
Study 33243030 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment (2 g/day)
Number of subjects: 40
Study 33243030 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes prenatal care (NICE guidelines)
Number of subjects: 40
Study 33243030 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 40
Study 33667309 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 81
Study 33667309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 32063619 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 5mg tablets per night for 3-7 days
Number of subjects: 220
Study 32063619 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate 50mg tablets per night for 3-7 days
Number of subjects: 220
Study 36184253 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg/day)
Number of subjects: 40
Study 36184253 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 40
Study 33789551 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer cases
Number of subjects: 22
Study 33789551 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer cases
Number of subjects: 22
Study 33789551 — intervention group
Group type: COMPARATOR
Intervention: Cancer-free controls
Number of subjects: 22
Study 32519676 — intervention group
Group type: EXPERIMENTAL
Intervention: Excerpts containing misspellings
Number of subjects: 301
Study 32519676 — intervention group
Group type: EXPERIMENTAL
Intervention: Excerpts containing inappropriate capitalization
Number of subjects: 301
Study 32519676 — intervention group
Group type: EXPERIMENTAL
Intervention: Excerpts containing both misspellings and inappropriate capitalization
Number of subjects: 301
Study 32519676 — intervention group
Group type: COMPARATOR
Intervention: Control excerpts
Number of subjects: 301
Study 35118644 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran-based prime
Number of subjects: 61
Study 35118644 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid prime
Number of subjects: 61
Study 34364737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulabandha yoga therapy (MYT) for 12 weeks
Number of subjects: 50
Study 34364737 — intervention group
Group type: COMPARATOR
Intervention: No MYT (control group)
Number of subjects: 50
Study 33203367 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor
Number of subjects: 1347
Study 33203367 — intervention group
Group type: COMPARATOR
Intervention: Pre-labor cesarean section
Number of subjects: 1347
Study 35887850 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMUFRA multicomponent frailty program for 20 weeks
Number of subjects: 81
Study 35887850 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMUFRA multicomponent frailty program
Number of subjects: 81
Study 35887850 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) continued routine activities
Number of subjects: 81
Study 35589771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dual task training (CDTT, n=9)
Number of subjects: 30
Study 35589771 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor dual task training (MDTT, n=11)
Number of subjects: 30
Study 35589771 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT, n=10)
Number of subjects: 30
Study 33596675 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy plus standard medical therapy
Number of subjects: 182
Study 33596675 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 182
Study 36066991 — intervention group
Group type: EXPERIMENTAL
Intervention: Eritoran (12 mg I.V. every 12 h)
Number of subjects: 19
Study 36066991 — intervention group
Group type: COMPARATOR
Intervention: Intralipid (30 ml/h) + vehicle
Number of subjects: 19
Study 36066991 — intervention group
Group type: COMPARATOR
Intervention: Saline (30 ml/h) + vehicle
Number of subjects: 19
Study 36066991 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid (30 ml/h) + eritoran (12 mg I.V. every 12 h)
Number of subjects: 19
Study 36066991 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 19